Efficacy of glucocorticoids for the treatment of macrolide refractory mycoplasma pneumonia in children: meta-analysis of randomized controlled trials
Abstract Background Mycoplasma pneumoniae is one of the most common pathogens causing community acquired pneumonia in children. Although the rate of macrolide-refractory Mycoplasma pneumoniae (MRMP) has increased, systemic glucocorticoids as a treatment option has not been validated yet. The purpose...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2019-12-01
|
| Seri Bilgileri: | BMC Pulmonary Medicine |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s12890-019-0990-8 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|